Wilfrid Richer

3.1k citations
24 papers · 894 indexed · h-index 14
Topics
Chromatin Remodeling and Cancer (8 papers)Cancer Immunotherapy and Biomarkers (7 papers)Cancer Mechanisms and Therapy (5 papers)
Partner nations
FranceArgentinaChile

In The Last Decade

Wilfrid Richer

24 papers receiving 884 citations

Peers

Wilfrid Richer
Comparison fields: 5 of 74
  • Molecular Biology 366
  • Immunology 347
  • Oncology 246
  • Pulmonary and Respiratory Medicine 154
  • Neurology 124
Replace Kentaro Fujii with:
Kentaro Fujii Japan
Agnès Moreau‐Aubry France
Katsuhiro Togami Japan
Sarah J. Hill United States
Kazutaka Uehira Japan
Erich Piovan Italy
Andrea Muscat Australia
Anna Onnis Italy
Emma Ivansson Sweden
Hongshan Zhao China
Wilfrid Richer relative to Kentaro Fujii Japan Kentaro Fujii's profile →
Citations per field
00.5×1.5×2.3×
Kentaro Fujii · 1×
Citations per year

Countries citing papers authored by Wilfrid Richer

Since Specialization
Citations

This map shows the geographic impact of Wilfrid Richer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wilfrid Richer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wilfrid Richer more than expected).

Fields of papers citing papers by Wilfrid Richer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wilfrid Richer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wilfrid Richer. The network helps show where Wilfrid Richer may publish in the future.

Co-authorship network of co-authors of Wilfrid Richer

This figure shows the co-authorship network connecting the top 25 collaborators of Wilfrid Richer. A scholar is included among the top collaborators of Wilfrid Richer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wilfrid Richer. Wilfrid Richer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 3
2 8
3 10
4 29
5 54
6 227
7 32
8 23
9 7
10 74
11 1
12 72
13 44
14 78
15 1
16 42
17 12
18 6
19 26
20 41

About Wilfrid Richer

Wilfrid Richer is a scholar working on Immunology, Developmental Biology and Oncology, having authored 24 papers that have together received 894 indexed citations. Recurring topics across this work include Chromatin Remodeling and Cancer (8 papers), Cancer Immunotherapy and Biomarkers (7 papers) and Cancer Mechanisms and Therapy (5 papers). The work is most often cited by research in Immunology (347 citations), Oncology (246 citations) and Neurology (124 citations). Wilfrid Richer has collaborated with scholars based in France, Argentina and Chile. Frequent co-authors include Eliane Piaggio, Franck Bourdeaut, Nicolás Gonzalo Núñez, Rodrigo Nalio Ramos, Olivier Delattre, Anne Vincent‐Salomon, Pierre Bourdely, Sofía Hidalgo, Pierre Guermonprez and Julie Helft. Their work appears in journals such as Nature Communications, Immunity and Bioinformatics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026